Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo

Gastroenterology

Volumn 116, Issue 5, 1999, Pages 1202-1216

  Kleeff, J ^a   Maruyama, H ^a   Ishiwata, T ^a   Sawhney, H ^a   Friess, H ^a   Buchler, M W ^a   Korc, M ^a  

^a Med Sci I 4475   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BONE MORPHOGENETIC PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; RECEPTOR PROTEIN;

ARTICLE; CANCER SURVIVAL; CELL ACTIVATION; CELL PROLIFERATION; DNA PROBE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MITOGENICITY; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION;

EID: 0032908128     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70024-7     Document Type: Article

References (46)

1. R Derynck JA Jarrett EY Chen DH Eaton JR Bell RK Assoian AB Roberts MB Sporn DV Goeddel Human transforming growth factor–beta complementary DNA sequence and expression in normal and transformed cells Nature 316 1985 701 705
2. L Madisen NR Webb TM Rose H Marquardt T Ikeda D Twardzik S Seyedin AF Purchio Transforming growth factor–beta 2: cDNA cloning and sequence analysis DNA 7 1988 1 8
3. P ten Dijke P Hansen KK Iwata C Pieler JG Foulkes Identification of another member of the transforming growth factor type beta gene family Proc Natl Acad Sci USA 85 1988 4715 4719
4. AJ Mason JS Hayflick N Ling F Esch N Ueno SY Ying R Guillemin H Niall PH Seeburg Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor–beta Nature 318 1985 659 663
5. JM Wozney V Rosen AJ Celeste LM Mitsock MJ Whitters RW Kriz RM Hewick EA Wang Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528 1534
6. BLM Hogan Bone morphogenetic proteins: multifunctional regulators of vertebrate development Genes Dev 10 1996 1580 1594
7. J Massagué F Weis-Garcia Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals Cancer Surv 27 1996 41 64
8. P ten Dijke H Ichijo P Franzén P Schulz J Saras H Toyoshima CH Heldin K Miyazono Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity Oncogene 8 1993 2879 2887
9. P ten Dijke H Yamashita H Ichijo P Franzén M Laiho K Miyazono CH Heldin Characterization of type I receptors for transforming growth factor–beta and activin Science 264 1994 101 104
10. F Liu F Ventura J Doody J Massagué Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs Mol Cell Biol 15 1995 3479 3486
11. PA Hoodless T Haerry S Abdollah M Stapleton MB O'Connor L Attisano JL Wrana MADR1, a MAD-related protein that functions in BMP2 signaling pathways Cell 85 1996 489 500
12. M Kretzschmar F Liu A Hata J Doody J Massagué The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase Genes Dev 11 1997 984 995
13. CH Heldin K Miyazono K ten Dijke TGF-β signalling from cell membrane to nucleus trough SMAD proteins Nature 390 1997 465 471
14. SA Hahn M Schutte AT Hoque CA Moskaluk LT da Costa E Rozenblum CL Weinstein A Fischer CJ Yeo RH Hruban SE Kern DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 1996 350 353
15. AL Warshaw C Fern'ndez-del Castillo Pancreatic carcinoma N Engl J Med 326 1992 455 465
16. B Gudjonsson Cancer of the pancreas. 50 years of surgery Cancer 60 1987 2284 2303
17. H Friess Y Yamanaka M Büchler M Ebert HG Beger LI Gold M Korc Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival Gastroenterology 105 1993 1846 1856
18. H Friess M Büchler M Kruger HG Beger Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserilin Pancreas 7 1992 516 521
19. H Friess M Büchler C Beglinger A Weber J Kunz K Fritsch HJ Dennler HG Beger Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer Pancreas 8 1993 540 545
20. M Korc B Chandrasekar Y Yamanaka H Friess M Büchler HG Beger Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha J Clin Invest 90 1992 1352 1360
21. AB Raitano M Korc Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line J Biol Chem 265 1990 10466 10472
22. RL Baldwin M Korc Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta–1 Growth Factors 8 1993 23 34
23. M Kornmann N Arber M Korc Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotox-icity to cisplatinum J Clin Invest 101 1998 344 352
24. J Kleeff T Ishiwata A Kumbasar H Friess MW Büchler AD Lander M Korc The cell-surface heparan sulfate proteoglycan glypi-can-1 regulates growth factor action in pancreatic carcinoma cells, and is overexpressed in human pancreatic cancer J Clin Invest 102 1998 1662 1673
25. J Itakura I Toshiyuki H Friess H Fujii Y Matsumoto MW Büchler M Korc Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression Clin Can Res 3 1997 1309 1316
26. J Hino M Takao N Takeshita Y Konno T Nishizawa H Matsuo K Kangawa cDNA cloning and genomic structure of human bone morphogenetic protein-3B (BMP-3b) Biochem Biophys Res Commun 223 1996 304 310
27. CD Logsdon L Keyes RD Beauchamp Transforming growth factor–beta (TGF-beta 1) inhibits pancreatic acinar cell growth Am J Physiol 262 1992 G364 G368
28. E Bhattacharyya A Panchal TJ Wilkins J deOndarza SR Hootman Insulin, transforming growth factors, and substrates modulate growth of guinea pig pancreatic duct cells in vitro Gastroenterology 109 1995 944 952
29. JN Ihle Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells Adv Cancer Res 68 1996 23 65
30. DJ Robbins E Zhen M Cheng D Ebert MH Cobb MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network Adv Cancer Res 63 1994 93 116
31. J Kleeff M Korc Up-regulation of transforming growth factor–β receptors by TGF-β1 in COLO-357 cells J Biol Chem 273 1998 7495 7500
32. M Schutte RH Hruban L Hedrick KR Cho GM Nadasdy CL Weinstein GS Bova WB Isaacs P Cairns H Nawroz D Sidransky RA Casero Jr PS Meltzer SA Hahn SE Kern DPC4 gene in various tumor types Cancer Res 56 1996 2527 2530
33. J Barnes CT Anthony N Wall MS Steiner Bone morphogenetic protein–6 expression in normal and malignant prostate World J Urol 13 1995 337 343
34. SE Harris MA Harris P Mahy J Wozney JQ Feng GR Mundy Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells Prostate 24 1994 204 211
35. M Katoh M Terada Overexpression of bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type J Gastroenterol 31 1996 137 139
36. S Hatakeyama YH Gao Y Ohara Nemoto H Kataoka M Satoh Expression of bone morphogenetic proteins of human neoplastic epithelial cells Biochem Mol Biol Int 42 1997 497 505
37. FC Hamdy P Autzen MC Robinson CH Horne DE Neal CN Robson Immunolocalization and messenger RNA expression of bone morphogenetic protein–6 in human benign and malignant prostatic tissue Cancer Res 57 1997 4427 4431
38. H Yoshikawa WJ Rettig JM Lane K Takaoka E Alderman B Rup V Rosen JH Healey AG Huvos P Garin Chesa Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas Cancer 74 1994 842 847
39. H Yoshikawa WJ Rettig K Takaoka E Alderman B Rup V Rosen JM Wozney JM Lane AG Huvos P Garin Chesa Expression of bone morphogenetic proteins in human osteosarcoma. Immuno-histochemical detection with monoclonal antibody Cancer 73 1994 85 91
40. N Yamada M Kato P ten Dijke H Yamashita TK Sampath CH Heldin K Miyazono K Funa Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours Br J Cancer 73 1996 624 629
41. H Friess J Kleeff MW Büchler Growth factors and growth factor receptors in chronic pancreatitis CG Dervenis Advances in pancreatic disease 1997 Georg Thieme Verlag Stuttgart, Germany: 26 32
42. M Korc Role of growth factors in pancreatic cancer Surg Oncol Clin North Am 7 1998 25 41
43. H Ide T Yoshida N Matsumoto K Aoki Y Osada T Sugimura M Terada Growth regulation of human prostate cancer cells by bone morphogenetic protein–2 Cancer Res 57 1997 5022 5027
44. M Kretzschmar J Doody J Massagué Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1 Nature 389 1997 618 622
45. MB Sporn AB Roberts Peptide growth factors are multifunctional Nature 332 1988 217 219
46. M Wagner J Kleeff ME Lopez I Bockmann J Massagué M Korc Transfection of the type I TGF-β receptor restores TGF-β1 responsiveness in pancreatic cancer Int J Cancer 78 1998 255 260